By Will Boggs, MD NEW YORK (Reuters Health) – Temsirolimus does not improve progression-free survival in metastatic renal cell carcinoma (RCC) compared to standard treatment, according to results…
NEW YORK (Reuters Health) – In patients with potentially resectable colorectal liver metastases, the use of combined PET and CT imaging (PET-CT) identifies those with occult extrahepatic disease…
Recent Videos in Reuters Health • The Doctor’s Channel Newscast Page 204
NEW YORK (Reuters Health) – Brown adipose tissue (BAT) is much more active in humans during the winter than in the summer, according to a report in the…
NEW YORK (Reuters Health) – In trauma patients with possible neck injury, paramedics can apply the Canadian C-Spine Rule to reliably avoid unnecessary spinal immobilization “without missing any…
NEW YORK (Reuters Health) – Active surveillance of prostate cancer, with intervention offered for progressive disease, appears to be safe even for intermediate-risk disease in men over the…
NEW YORK (Reuters Health) – Chronic renal disease appears to reduce platelet responsiveness to clopidogrel, according to a Korean research team. Furthermore, increasing the dose of clopidogrel does…
NEW YORK (Reuters Health) – Provocative clinical tests — palpation for nerve thickening and local tenderness, Tinel’s test and flexion compression tests – are of little value in…
NEW YORK (Reuters Health) – New research indicates that breastfeeding requires no more (or less) resting energy expenditure (REE) than bottle-feeding in preterm infants. This finding runs counter…
NEW YORK (Reuters Health) – New research confirms that tubular carcinoma (TC) of the breast has an excellent prognosis and goes on to show that outcomes are better…
NEW YORK (Reuters Health) – Transfusion of two rather than one unit of partially HLA-matched umbilical cord blood (UCB) appears to reduce the risk of relapse in leukemia…
NEW YORK (Reuters Health) – For pregnant women who require chronic anticoagulation, low molecular weight heparin (LMWH) is an alternative to warfarin, but not an ideal one, according…
NEW YORK (Reuters Health) – In patients with nonischemic dilated cardiomyopathy, the left ventricular (LV) pacing site is a key determinant of the hemodynamic response to resynchronization –…
